Publications by authors named "V Chervinko"

Background: Present concepts of the novel coronavirus infection prognosis in haemodialysis (HD) patients are rather controversial. There is little information on therapy efficiency and safety in such patients. We studied COVID-19 course specifics, prognostic factors associated with fatal outcomes, therapy efficiency and its transformation at different stages of the pandemic first year.

View Article and Find Full Text PDF

Treatment of hemodialysis patients infected with two or three hepatitis C virus (HCV) genotypes (Gt) with interferon-free regimens has not been possible until the recent introduction of pan-genotypic next generation therapy. The main reason is that sofosbuvir (SOF)-containing regimens are contraindicated in patients with low glomerular filtration rate. We describe here a case of a chronic HCV infection in a patient with end-stage renal disease, successfully treated with gleсaprevir/pibrentasvir (GLE/PIB).

View Article and Find Full Text PDF

Polymyalgia rheumatica (PMR) is a rare chronic inflammatory disease. It predominantly affects the elderly. The disease has a slow onset, pain and stiffness in the muscles of the shoulder and pelvic girdle, fever, weight loss, and a high acute-phase inflammatory response.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatitis C virus (HCV) infection can lead to chronic liver issues like cirrhosis and liver cancer, as well as various extrahepatic diseases due to its impact on both liver and lymphatic systems.
  • The most notable consequences include mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma, which arise from prolonged B cell stimulation by the virus.
  • The review focuses on the connections between chronic HCV infection and lymphoproliferative disorders, autoimmune disorders, and kidney damage.
View Article and Find Full Text PDF

Hepatitis C virus (HCV) infection results in not only chronic hepatitis and subsequent complications as liver cirrhosis and hepatocellular carcinoma, but also in a significant number of other diseases, the so-called extrahepatic manifestations of chronic HCV infection. In addition to lymphoproliferative and autoimmune disorders discussed in Part 1 of this review, many other diseases turned to be associated with chronic HCV infection. Part 2 of this review is dedicated to the analysis of the relationship of chronic HCV-infection to the development of some endocrine diseases, such as thyroiditis and diabetes mellitus, and cardiovascular disorders.

View Article and Find Full Text PDF